Stocks to sell

What’s the latest with Clover Health (NASDAQ:CLOV) stock? To be honest, not much. Since I last wrote about CLOV stock on Sept. 16, the situation with the meme stock favorite hasn’t changed. The Medicare Advantage plan provider’s key issue, its challenges to become profitable, is still CLOV’s biggest challenge. Source: Shutterstock Along with this, the

Globalstar (NYSEAMERICAN:GSAT) is a highly speculative global satellite company that is coming off peak speculation. GSAT stock peaked at $2.69 on hopes that Apple (NASDAQ:AAPL) was going to sign up with the company. When that didn’t happen during a recent Sept. 14 conference, the stock started falling. Unfortunately, it probably has much lower to go.

Camber Energy (NYSE:CEI) is best seen as a holding company with a 62% interest in another oil and gas company, Viking Energy (OTCMKTS:VKIN). The issue is CEI stock has spiked on a speculative deal it recently signed with a third company, privately held ESG Clean Energy (“ESG”). Source: Shutterstock ESG says it has a way

Plug Power (NASDAQ:PLUG), the hydrogen fuel cell company, was somehow able to raise more than $3.4 billion in two different tranches in January and February 2021. The company sold $1.6 billion of PLUG stock at $29.29 in February to a subsidiary of SK Holdings, the third-largest conglomerate in South Korea. Source: Shutterstock Additionally, it managed

Any investment in Ocugen (NASDAQ:OCGN) stock is based on hope. That hope involves the FDA approving the Covid-19 vaccine known as Covaxin.    Source: shutterstock.com/PhotobyTawat Over the last six months or so, the company has repeatedly suggested that such an approval was imminent. On Feb. 2,  Ocugen announced an agreement with the Indian drug maker

Just one month ago, sentiment surrounding mobile e-commerce company ContextLogic (NASDAQ:WISH) was positive. Seven analysts considered WISH stock a “buy” and four others rated the stock a “hold.” But these days, sentiment has darkened considerably. Currently, only three analysts have a “buy” rating on WISH stock, with six saying it’s a “hold” and two more

SoFi Technologies (NASDAQ:SOFI) is aiming to upend the banking industry. The Silicon Valley startup initially focused on the student lending market. It has since branched out into a wide variety of other banking and brokerage products. SOFI stock went public earlier this year via a special purpose acquisition company (SPAC) and has been well-received by

MicroVision (NASDAQ:MVIS) is still up for sale, at least according to the company’s latest 10-Q report. The reason is pretty simple. It still only has one customer for its Lidar products. And that is on a royalty revenue basis. This leaves MVIS stock fairly overvalued at the present time. Source: shutterstock.com/temp-64GTX I have written about

I can understand why people like ContextLogic (NASDAQ:WISH) stock. There are some compelling reasons why you’d want to root for this underdog. Source: sdx15 / Shutterstock.com Unfortunately, there aren’t enough of those reasons based in fact to make WISH stock a very compelling investment. So, as much as it would be fun to put your

The current situation in clean energy stocks reminds several analysts of the dot-com boom in the late 1990s. According to data from Morningstar, global inflows into clean energy exchange-traded funds (ETFs) jumped to $14.7 billion in the six months to the end of March, up from only $1.3 billion in the same period a year

Tesla (NASDAQ:TSLA) created the electric car market, starting with the luxury end and working down. Source: Sheila Fitzgerald / Shutterstock.com This has made CEO Elon Musk a centi-billionaire. TSLA stock was worth $741 billion as trading began September 22. The company was only marginally profitable until its June quarter report showed it bringing nearly $1

Restaurant stocks have had a challenging couple of years now. The U.S. economy was almost on full throttle earlier this year, nearly hitting escape velocity from the pandemic. But things turned around as the year progressed. Now we sit on variety of conflicting economic indicators — some encouraging, other flashing warning signs. And so, while

Sesen Bio (NASDAQ:SESN) is a small biotech company attempting to develop a drug it calls Vicineum. SESN stock plunged last month after hitting a massive regulatory setback. Source: luchschenF / Shutterstock.com Sesen’s Vicineum aims to treat unresponsive non-muscle invasive bladder cancer using a locally administered recombinant fusion protein method. However, the Food and Drug Administration

When I wrote about Nio (NYSE:NIO) last month, I argued that the risks that could send NIO stock lower outweighed factors that could help it bounce back. Source: Robert Way / Shutterstock.com The Chinese electric vehicle (EV) maker has numerous strengths, such as high projected rates of growth in its home market. It also has

Peloton Interactive (NASDAQ:PTON) is wildly overvalued at its present valuation of $30.3 billion. A major reason is that the company’s latest quarter showed a massive loss in free cash flow. This adds up to a cash crunch for Peloton sometime in the near future if this trend continues. And that is not going to fare

Aterian (NASDAQ:ATER) is a consumer products platform that, according to Yahoo! Finance, uses software which implements “machine learning, natural language processing, and data analytics to design, develop, market, and sell products.” Essentially, Aterian scales consumer brands. But what should you know about ATER stock? Source: Shutterstock This company calls itself a “leading consumer product platform” —

Earlier this month, Alibaba (NYSE:BABA) looked as though it had bottomed. Speculators bet on BABA stock bottoming at $160 by bidding the stock up close to $180, its 50-day simple moving average. Source: BigTunaOnline / Shutterstock.com The rally did not last because traders failed to account for the ongoing political risks and the massive “forced

As one of the most widely followed SPAC offerings this year, Clover Health (NASDAQ:CLOV) has not exactly set the world on fire. After debuting on Jan. 8, the stock has mostly drifted downward with the exception of a short-term trading boost earlier this summer. CLOV stock currently has a $3.4 billion market capitalization and $412

Down 42% year-to-date, ChargePoint (NYSE:CHPT) stock does not look worthy of investor’s money. Source: JL IMAGES / Shutterstock.com The largest manufacturer of electric vehicle charging stations in the world looks good on paper, but so far its potential has not translated into success for shareholders. ChargePoint went public earlier this year at the height of the

Vinco Ventures (NASDAQ:BBIG) stock is the latest meme play. But if you blink, you might miss it. Source: Michael Vi via Shutterstock Vinco is an investment company that has gotten into non fungible tokens (NFTs), launching an E-NFT platform for trading them. It also owns 80% of a short video content platform (think TikTok) called